ECC 2013 Immuno-Oncology Satellite Symposium supported by Bristol-Myers Squibb. Immuno-Oncology: the next new paradigm in cancer treatment?

Prof. Zitvogel outlines the current understanding of the interaction between the immune system and cancer, defining the key cells and pathways, and exploring the complex and overlapping mechanisms tumours use to escape detection and/or destruction by the immune system and how these have emerged as therapeutic targets.

To view the slides fullscreen click the square and arrows button at the bottom right of the player.